Showing posts with label Cancer. Show all posts
Showing posts with label Cancer. Show all posts

Tuesday, November 23, 2010

FDA committee considers Gardasil for anal cancer prevention

The human papillomavirus vaccine Gardasil moved closer to an indication for anal cancer prevention after a meeting of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee on Nov. 17.
The vaccine, manufactured by Merck & Co. Inc., is

Friday, November 19, 2010

New chemotherapeutic agent approved for use in late-stage breast cancer

On November 15, 2010, the US Food and Drug Administration announced the approval of Halaven (eribulin mesylate) for the treatment of patients with metastatic breast cancer who have received at least 2 prior chemotherapy regimens for late-stage disease.

Monday, October 25, 2010

FDA approves trastuzumab for HER2-positive gastric cancer

The Food and Drug Administration has approved trastuzumab, along with chemotherapy, to treat metastatic HER2-positive gastric cancers in people who have not been previously treated for metastatic disease.
The agency’s decision, announced

Sunday, October 10, 2010

New Cancer therapy Put an End to Chemotherapy

Scientists have developed a new cancer treatment that can safely deliver extremely high chemotherapy doses with minimal side effects.
Excited scientists say the new-generation drug, to be announced at a leading cancer conference this week, could be used effectively against many types of tumour, reports the Daily Express.
New Cancer therapy Put an End to Chemotherapy

Saturday, October 2, 2010

Caffein May reduce Brain Cancer Risk

A daily cup of tea or coffee can protect you from brain cancer, a study has found.
People who drink one cup of either hot drink can slash the risk of the disease by a third
Docto Update: Caffein May reduce Brain Cancer Risk

No Benefit for Early Tx of Ovarian Cancer Relapse

Women who get early chemotherapy for a recurrence of ovarian cancer won't live longer, researchers say.
Survival rates weren't significantly different between those who started chemotherapy once

Thursday, September 30, 2010

IUD May Be Therapy for Endometrial Cancer

An intrauterine contraceptive device -- impregnated with the progestin levonorgestrel -- may successfully treat atypical endometrial hyperplasia and early stage endometrial cancer in young women while preserving their fertility, according to a small prospective study.

Wednesday, September 29, 2010

Blood Test May Spot Early Colon Cancer

A simple blood test may help identify colon cancer early, when it is in its most treatable stages.

Although the research is still in its infancy, "we are trying to develop a test that can be integrated into an annual checkup that is just another box for a doctor to check on the menu of blood tests

Tuesday, September 28, 2010

Darbepoetin worsens 5-year survival in head and neck cancer

The erythropoiesis-stimulating agent darbepoetin alfa should not be used in combination with radiotherapy in patients with potentially curable head and neck cancer, late results of the halted Danish Head and Neck Cancer Study Group 10 trial indicate

Vaginal brachytherapy improves 5-year quality of life in endometrial cancer

Vaginal brachytherapy for high-intermediate risk endometrial cancer is associated with significantly less diarrhea and fewer bowel symptoms that limit patients’ daily activities, compared with pelvic external beam radiation therapy, according to 5-year follow-up data from a phase III trial.
The latest findings from the open-label, randomized

Monday, September 27, 2010

statin-cancer link not proved

STOCKHOLM (EGMN) – Data from 170,000 patients in 26 randomized trials may finally dismiss the idea that low cholesterol levels during statin therapy play a role in causing cancer.
“The results are really very reassuring. There is no evidence that cancer risk is